Approvals/TGA/ERLOTINIB CIPLA erlotinib (as hydrochloride) 25 mg tablet blister pack

Approved

STANDARD

ERLOTINIB CIPLA erlotinib (as hydrochloride) 25 mg tablet blister pack

Cipla Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 892de21d91cb6464
Product Name: ERLOTINIB CIPLA erlotinib (as hydrochloride) 25 mg tablet blister pack
Artg Id: 337796
Artg Name: ERLOTINIB CIPLA erlotinib (as hydrochloride) 25 mg tablet blister pack
Sponsor: Cipla Australia Pty Ltd
Company Detail Path: /organization/cipla-australia-pty-ltd
Artg Date: 2021-04-30
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/ece5bb5513e66bbfecd5f51737afcfe5.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/2038f2d2c2d378bf60441addde923b71.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

892de21d91cb6464

Type

Standard